Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Signaling Nodes Associated with Endoplasmic Reticulum Stress during NAFLD Progression
Ja Hyun Koo, Chang Yeob Han
Biomolecules (2021) Vol. 11, Iss. 2, pp. 242-242
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Metabolic-associated fatty liver disease and lipoprotein metabolism
Jöerg Heeren, Ludger Scheja
Molecular Metabolism (2021) Vol. 50, pp. 101238-101238
Open Access | Times Cited: 391
Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD)
Christina‐Maria Flessa, Ioannis Kyrou, Narjes Nasiri‐Ansari, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1585-1606
Closed Access | Times Cited: 46
(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease
Lucia Longhitano, Alfio Distefano, Nicolò Musso, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases
Devaraj Ezhilarasan, Lakshmi Thangavelu
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Endoplasmic reticulum stress PERK-ATF4-CHOP pathway is involved in non-alcoholic fatty liver disease in type 1 diabetic rats: The rescue effect of treatment exercise and insulin-like growth factor I
Shadi Mohammadpour-Asl, Behrad Roshan-Milani, Shiva Roshan‐Milani, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27225-e27225
Open Access | Times Cited: 5
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
Ke Zhao, Heng Zhang, Wenyu Ding, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis
Kentaro Murakami, Yusuke Sasaki, Masato Asahiyama, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 720-720
Open Access | Times Cited: 24
Exercise and Metformin Intervention Prevents Lipotoxicity-Induced Hepatocyte Apoptosis by Alleviating Oxidative and ER Stress and Activating the AMPK/Nrf2/HO-1 Signaling Pathway in db/db Mice
Yuan Zhang, Yuting Liu, Liu Xiao-wei, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 23
Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
Sou Hyun Kim, Chawon Yun, Doyoung Kwon, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1476-1476
Open Access | Times Cited: 14
The Role of Endoplasmic Reticulum Stress in Metabolic Diseases
Fı̇rdevs Sak, Fatma Şengül, Hüsamettin Vatansev
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 7, pp. 487-493
Closed Access | Times Cited: 4
Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
Harsh Vardhan Charan, Durgesh Kumar Dwivedi, Sabbir Khan, et al.
Genes & Diseases (2022) Vol. 10, Iss. 2, pp. 480-494
Open Access | Times Cited: 21
The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
Camelia Munteanu, Betty Schwartz
Antioxidants (2023) Vol. 12, Iss. 4, pp. 903-903
Open Access | Times Cited: 12
GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
Haoran Jiang, Linquan Zang
Current Pharmaceutical Design (2024) Vol. 30, Iss. 2, pp. 100-114
Closed Access | Times Cited: 3
FXR activation remodels hepatic and intestinal transcriptional landscapes in metabolic dysfunction-associated steatohepatitis
Yingquan Wen, Zi-Yuan Zou, Guanguan Zhao, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2313-2327
Closed Access | Times Cited: 2
Role of Ca2+ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)
Xingyue Chen, Li Zhang, Liming Zheng, et al.
International Journal of Molecular Medicine (2022) Vol. 50, Iss. 3
Open Access | Times Cited: 11
Oyster broth concentrate and its major component taurine alleviate acute alcohol‐induced liver damage
Adrian S. Siregar, Marie Merci Nyiramana, Eun‐Jin Kim, et al.
Food Science & Nutrition (2022) Vol. 10, Iss. 7, pp. 2390-2399
Open Access | Times Cited: 9
Endoplasmic Reticulum Stress Activates Hepatic Macrophages through PERK-hnRNPA1 Signaling
Ari Kwon, Yun Seok Kim, Jiyoon Kim, et al.
Biomolecules & Therapeutics (2024) Vol. 32, Iss. 3, pp. 341-348
Open Access | Times Cited: 1
HA15 alleviates bone loss in ovariectomy-induced osteoporosis by targeting HSPA5
Chao Han, Kegong Xie, Chengliang Yang, et al.
Experimental Cell Research (2021) Vol. 406, Iss. 2, pp. 112781-112781
Closed Access | Times Cited: 8
Roles of PPARα and PPARγ As Regulator of Free Fatty Acids in Nonalcoholic Steatohepatitis
Hung Thai Vu, Vien Duc Nguyen, Tsutomu Matsubara
(2023)
Open Access | Times Cited: 2
Supplementation with optimized multivitamin premix relieves liver steatosis by inhibiting CD36 palmitoylation and regulating intestinal microorganisms in largemouth bass (Micropterus salmoides)
Luohai Hua, Haokun Liu, Mingze Xin, et al.
Aquaculture Reports (2024) Vol. 36, pp. 102098-102098
Open Access
Esrra regulates Rplp1-mediated translation of lysosome proteins suppressed in metabolic dysfunction-associated steatohepatitis and reversed by alternate day fasting
Madhulika Tripathi, Karine Gauthier, Reddemma Sandireddy, et al.
Molecular Metabolism (2024) Vol. 87, pp. 101997-101997
Open Access
Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1876-1876
Open Access
A weekly 4‐methylpyrazole treatment attenuates the development of non‐obese metabolic dysfunction‐associated steatotic liver disease (MASLD) in male mice: Role of JNK
Katharina Burger, Finn Jung, Raphaela Staltner, et al.
European Journal of Clinical Investigation (2024)
Open Access
Hepatic Insulin Resistance Model in the Male Wistar Rat Using Exogenous Insulin Glargine Administration
Víctor Enrique Sarmiento-Ortega, Diana Moroni-González, Alfonso Díaz, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 572-572
Open Access | Times Cited: 1
Identification of Key Endoplasmic Reticulum Stress-Related Genes in Non-Alcoholic Fatty Liver Disease
Zhuang Li, Haozhen Yu, Jun Li
BioMedInformatics (2022) Vol. 2, Iss. 3, pp. 424-433
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top